The b-wave of the electroretinogram as an index of retinal ischemia

General Pharmacology

Volumn 30, Issue 3, 1998, Pages 281-287

  Block, F ^a   Schwarz, M ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Electroretinogram; Protection; Retinal ischemia

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; ALPHA TOCOPHEROL; CATALASE; DIZOCILPINE; EMOPAMIL; FLUPIRTINE; FREE RADICAL; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; MEMANTINE; NIMODIPINE; SCAVENGER; SUPEROXIDE DISMUTASE; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; B WAVE; CONFERENCE PAPER; DRUG EFFECT; ELECTRORETINOGRAM; INTRAOCULAR PRESSURE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REPERFUSION; RETINA ARTERY OCCLUSION; RETINA ISCHEMIA;

ANIMALS; ELECTRORETINOGRAPHY; ISCHEMIA; RETINA; RETINAL DISEASES; RETINAL VESSELS;

EID: 0032033296     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(97)00359-5     Document Type: Conference Paper

References (62)

1. Barnett N. L., Osborne N. N. Prolonged bilateral carotid artery occlusion induces electrophysiological and immunohistochemical changes to the rat retina without causing histological damage. Exp. Eye Res. 61:1995;83-90. . a.
2. Barnett N. L., Osborne N. N. Redistribution of GABA immunoreactivity following central retinal artery occlusion. Brain Res. 677:1995;337-340. . b.
3. Bast A., Haenen R. M. M. Interplay between lipoic acid and gluthathione in the protection against microsomal lipid peroxidation. Biochem. Biophys. Acta. 963:1988;558-561.
4. Blauth C., Smith P., Newman S., Arnold J., Siddons F., Harrison M. J., Treasure T., Klinger L., Taylor K. M. Retinal microembolism and neuropsychological deficit following clinical cardiopulmonary bypass. comparison of a membrane and a bubble oxygenator Eur. J. Cardiothorac. Surg. 3:1989;135-138.
5. Block F., Schwarz M. Effects of antioxidants on ischemic retinal dysfunction. Exp. Eye Res. 64:1997;559-564.
6. Block F., Jaspers R. M. A., Heim C., Sontag K.-H. S-Emopamil ameliorates ischemic brain damage in rats. histological and behavorial approaches Life Sci. 47:1990;1511-1518.
7. Block F., Schwarz M., Sontag K.-H. Retinal ischemia induced by occlusion of both common carotid arteries in rats as demonstrated by electroretinography. Neurosci. Lett. 144:1992;124-126.
8. Block F., Szabo L., Jaspers R. M. A., Heim C., Sontag K.-H. Levemopamil reduces spatial learning deficit following transient occlusion of common carotid arteries in normotensive rats. Acta Neurol. Scand. 88:1993;35-40.
9. Block F., Pergande G., Schwarz M. Flupirtine protects against ischaemic retinal dysfunction in rats. NeuroReport. 5:1994;2630-2632.
10. Block F., Schmitt W., Schwarz M. Pretreatment but not posttreatment with GYKI 52466 reduces functional deficits and neuronal damage after global ischemia in rats. J. Neurol. Sci. 139:1996;167-172.
11. Block F., Pergande G., Schwarz M. Flupirtine reduces functional deficits and neuronal damage after global ischemia in rats. Brain Res. 754:1997;279-284.
12. Bortolotto Z. A., Heim C., Sieklucka M., Block F., Sontag K.-H., Cavalheiro E. A. Effects of bilateral clamping of carotid arteries on hippocampal kindling in rats. Physiol. Behav. 49:1991;667-671.
13. Bresnick G. A. Excitotoxins. a possible new mechanism for the pathogenesis of ischemic retinal damage Arch. Ophthalmol. 107:1989;339-341.
14. Buchan A. M., Slivka A., Xue D. The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke. Brain Res. 574:1992;171-177.
15. Büchi E. R., Suivaizdis I., Fu J. Pressure-induced retinal ischemia in rats. an experimental model for quantitative study Ophthalmologica. 230:1991;138-147.
16. Busse E., Zimmer G., Schopohl B., Kornhuber B. Influence of α-lipoic acid on intracellular glutathione in vitro and in vivo. Arzneim-Forsch Drug Res. 42:1992;829-831.
17. Coleman K., Fitzgerald D., Eustace P., Bouchier-Hayes D. Electroretinography, retinal ischemia and carotid artery disease. Eur. J. Vasc. Surg. 4:1990;13-18.
18. Crosson C. E., Willis J. A., Potter D. E. Effect of the calcium antagonist, nifedipine, on ischemic retinal dysfunction. J. Ocul. Pharmac. 6:1990;293-299.
19. Delbarre G., Delbarre B., Calinon F., Ferger A. Accumulation of amino acids and hydroxyl free radicals in brain and retina of gerbil after transient ischemia. J. Ocul. Pharmac. 7:1991;147-155.
20. Demant E., Nagahara K., Niemeyer G. Effects of changes in systemic blood pressure on the electroretinogram of the cat. evidence for retinal autoregulation Invest. Ophthalmol. Visual Sci. 23:1982;683-687.
21. Donevan S. D., Rogawski N. A. GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron. 10:1993;51-59.
22. Dugan J. D., Green W. R. Ophthalmologic manifestation of carotid occlusive disease. Eye. 5:1991;226-238.
23. Fishman G. A., Sokol S. Electrophysiologic testing in disorders of the retina, optic nerve and visual pathway. 1990;American Academy of Ophthalmology, San Francisco.
24. Gehlbach P. L., Purple R. L. A paired comparison of two models of experimental retinal ischemia. Curr. Eye Res. 13:1994;597-602.
25. Green E. J., Pazos A. J., Dietrich W. D., McCabe P. M., Schneiderman N., Lin B., Busto R., Globus M. Y. T., Ginsberg M. D. Combined postischemic hypothermia and delayed MK-801 treatment attenuates neurobehavioral deficits associated with transient global ischemia in rats. Brain Res. 702:1995;145-152.
26. Gryglewski R. J., Palmer R. M. J., Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 320:1986;454-456.
27. Gupta L. Y., Marmor M. F. Mannitol, dextromethorphan, and catalase minimize ischemic damage to retinal pigment epithelium and retina. Arch. Ophthalmol. 111:1993;384-388.
28. Gurevich L., Slaughter M. M. Comparisons of the wave-forms of the on bipolar neuron and the b-wave of the electroretinogram. Visual Res. 33:1993;2431-2435.
29. Hofmann H. P., Raschak M., Unger L. S-Emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders, 1st communication. pharmacological profile Drug Res. 39:1989;304-308.
30. Huettner J. E., Bean B. P. Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801. selective binding to open channels Proc. Natl. Acad. Sci. USA. 85:1988;1307-1311.
31. Hughes W. F. Quantitation of ischemic damage in the rat retina. Exp. Eye Res. 53:1991;573-582.
32. Hunter A. J., Green A. R., Cross A. J. Animal models of acute ischaemic stroke. can they predict clinically successful neuroprotective drugs? Trends Pharmac. Sci. 16:1995;123-128.
33. Jaspers R., Block F., Heim C., Sontag K. H. Spatial learning is affected by transient occlusion of common carotid arteries (2VO). comparison of behavioral and histopathological changes after 2VO and 4-vessel occlusion in rats Neurosci. Lett. 117:1990;149-153.
34. Longa E., Weinstein P. R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:1989;84-91.
35. Lopez T., Lopez-Colome A. M., Ortega A. AMPA/KA receptor expression in radial glia. Neuroreport. 5:1994;504-506.
36. Louzada-Junior P., Dias J. J., Santos W. F., Lachat J. J., Bradford H. F., Coutinho-Netto J. Glutamate release in experimental ischemia of the retina. an approach using microdialysis J. Neurochem. 59:1992;358-363.
37. Miller R. F., Dowling J. E. Intracellular responses of the Müller (glial) cells of mudpuppy retina. their relation to b-wave of the electroretinogram J. Neurophysiol. 33:1970;323-341.
38. Mosinger J. L., Price M. T., Bai H. Y., Xiao H., Wozniak D. F., Olney J. W. Blockade of both NMDA and non-NMDA receptors is required for optimal protection against ischemic neuronal degeneration in the adult in vivo mammalian retina. Exp. Neurol. 113:1991;10-17.
39. Mossakowski M. J., Gadamski R. Nimodipine prevents delayed neuronal death of sector CA1 pyramidal cells in short-term forebrain ischemia in Mongolian gerbils. Stroke. 21(Suppl. 4):1990;120-122.
40. Nakayama H., Ginsberg M. D., Dietrich W. D. S-Emopamil, a novel calcium channel blocker and serotonin S2 antagonist, markedly reduces infarct size following middle cerebral artery occlusion in the rat. Neurology. 38:1988;1667-1673.
41. Nayak M. S., Kita M. M., Marmor M. F. Protection of rabbit retina from ischemic injury by superoxide dismutase and catalase. Invest. Ophthalmol. Visual Sci. 34:1993;2018-2022.
42. Osborne N. N., Block F., Sontag K.-H. Reduction in ocular blood flow results in GFAP expression in rat retinal Müller cells. Visual Neurosci. 7:1991;637-639.
43. Osborne N. N., Pergande G., Block F., Schwarz M. Immunohistochemical evidence for flupirtine acting as an antagonist on the N-methyl-D-aspartate and homocsyteic acid-induced release of GABA in the rabbit retina. Brain Res. 667:1994;291-294.
44. Osborne N. N., Larsen A., Barnett N. L. Influence of excitatory amino acids and ischemia on rat retinal choline acetyltransferase-containing cells. Invest. Ophthalmol. Visual Sci. 36:1995;1692-1700.
45. Osborne N. N., Schwarz M., Pergande G. Protection of rabbit retina from ischemic injury by flupirtine. Invest. Ophthalmol. Vis. Sci. 37:1996;274-280.
46. Paxinos G. The Rat Nervous System. 2:1995;Academic Press, San Diego. pp. 3-35.
47. Pulsinelli W. A., Levy D. E., Duffy T. E. Regional cerebral blood flow and glucose metabolism following transient forebrain ischemia. Ann. Neurol. 11:1982;499-509. . a.
48. Pulsinelli W. A., Brierley J. B., Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann. Neurol. 11:1982;491-498. . b.
49. Sato P. H., Hall E. D. Tirilazad protects vitamins C and E in brain ischemia-reperfusion injury. J. Neurochem. 58:1992;2263-2268.
50. Schwarz M., Schmitt T., Pergande G., Block F. N-Methyl-D-aspartate and α2-adrenergic mechanisms are involved in the depressant action of flupirtine on spinal reflexes in rats. Eur. J. Pharmac. 276:1995;247-255.
51. Sieklucka M., Bortolotto Z. A., Heim C., Block F., Sontag K.-H. Decreased susceptibility to seizures induced by bicuculline after transient bilateral clamping of the carotid arteries in rats. J. Neural Transm. 83:1991;127-137.
52. Siesjö B. K. Pathophysiology and treatment of focal cerebral ischemia II. mechanisms of damage and treatment J. Neurosurg. 77:1992;337-354.
53. Smith S. E., Meldrum B. S. Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, GYKI 52466, after focal ischemia in the rat. Stroke. 23:1992;861-864.
54. Szabo M. E., Droy-Lefaix M. T., Doly M., Carre C., Braquet P. Ischemia and reperfusion-induced histologic changes in the rat retina. Invest. Ophthalmol. Visual Sci. 32:1991;1471-1478.
55. Tamura A., Graham D. I., McCulloch J., Teasdale G. M. Focal cerebral ischemia in the rat I. description of technique and early neuropathological consequences following middle cerebral artery occlusion J. Cereb. Blood Flow Metab. 1:1981;53-60.
56. Uematsu D., Greenberg J. H., Hickey W. F., Reivich M. Nimodipine attenuates both increase in cytosolic free calcium and histologic damage following focal cerebral ischemia and reperfusion in cats. Stroke. 20:1989;1531-1537.
57. Veriac S., Tissie G., Bonne C. Oxygen free radicals adversely affect the regulation of vascular tone by nitric oxide in the rabbit retina under high intraocular pressure. Exp. Eye Res. 56:1993;85-88.
58. Wahlgren N. G., MacMahon D. G., De Keyser J., Indredavik B., Ryman T. Intravenous nimodipine West European stroke trial (Inwest) of nimodipine in the treatment of acute ischemic stroke. Cerebrovasc. Dis. 4:1994;204-210.
59. Wassmann H., Marinov M., Moskopp D. Effects of nimodipine in experimental permanent focal cerebral ischemia. Zentralbl. Neurochir. 53:1992;141-147.
60. Winterkorn J. M. S., Teman A. J. Recurrent attacks of amaurosis fugax treated with calcium channel blocker. Ann. Neurol. 30:1991;423-425.
61. Wright J. W., Clemens J. A., Panetta J. A., Smalstig E. B., Stubley Weatherly L. A., Kramár E. A., Pederson E. S., Mungall B. H., Harding J. W. Effects of LY231617 and angiotensin IV on ischemia-induced deficits in circular water maze and passive avoidance performance in rats. Brain Res. 717:1996;1-11.
62. Zager E. L., Ames A. Reduction of cellular energy requirements. screening for agents that may protect against CNS ischemia J. Neurosurg. 69:1988;568-579.